Pulmonary Coccidioidomycosis

 

 Buy Article Permissions and Reprints

ABSTRACT

Coccidioidal infection can manifest as pulmonary or extrapulmonary disease. Pulmonary coccidioidomycosis occurs in 95% of all cases and can be divided into three main categories: primary, complicated, and residual pulmonary coccidioidomycosis.

The primary infection occurs with inhalation of airborne arthroconidia. As few as 10 arthroconidia are capable of causing an infection in animal models. Sixty percent of infected individuals will remain asymptomatic. This results in a positive skin test and, with rare exception, lifelong immunity. The other 40% will develop symptomatic disease that manifests with variable signs and symptoms, predominantly an influenza-like syndrome, pneumonia, or pleural effusion.

The category of complicated pulmonary coccidioidomycosis includes clinical entities as severe and persistent pneumonia, progressive primary coccidioidomycosis, fibrocavitary coccidioidomycosis, cavities, and empyema, a complication of a ruptured cavity. Progression of primary pulmonary disease to acute respiratory distress syndrome (ARDS) can also qualify as a complication.

The third category of residual disease comprises only two entities: pulmonary nodule and fibrosis. This review focuses on uncomplicated and complicated pulmonary coccidioidomycosis and its management as outlined earlier in addition to special considerations of coccidioidal fungemia, pulmonary coccidioidomycosis in pregnancy, and organ transplantation.

REFERENCES

• 1 Posadas A. Ensayo anatomopatologico sobre una neoplasia considerada como micosis fungoidea.  An Circ Méd Argent. 1892;  15-18
  PubMedGoogle Scholar
• 2 Rixford E, Gilchrist T C. Two cases of protozoan (coccidioidal) infection of the skin and other organs.  Johns Hopkins Hosp Rep. 1896;  209-268
  PubMedGoogle Scholar
• 3 Dickson E C. Coccidioidomycosis; the preliminary acute infection with fungus coccidioides.  JAMA. 1938;  111 1362-1364
  PubMedGoogle Scholar
• 4 Gifford M A, Buss W C, Douds R J. Data on Coccidioides fungus infection, Kern County, 1900-1936. In: Kern County Health Department, Annual Report 1936-1937: 39-54
  Google Scholar
• 5 Ophüls W. Further observations on a pathogenic mould formerly described as a protozoon (Coccidioides immitis, Coccidioides pyogenes).  J Exp Med. 1905;  6 443-486
  CrossrefPubMedGoogle Scholar
• 6 Fischer M C, Koenig G L, White T J, Taylor J W. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis .  Mycologia. 2002;  94 73-84
  CrossrefPubMedGoogle Scholar
• 7 Stevens D A. Coccidioidomycosis.  N Engl J Med. 1995;  332 1077-1082
  CrossrefPubMedGoogle Scholar
• 8 Johnson R H, Munoz A D, Ragland A S. Soil borne illnesses. In: Lessenger J Handbook of Agricultural Medicine. New York; Springer-Verlag 2005
  Google Scholar
• 9 Petersen L R, Marshall S L, Barton-Dickson C et al.. Coccidioidomycosis among workers at an archaeological site, northeastern Utah.  Emerg Infect Dis. 2004;  10 637-642
  CrossrefPubMedGoogle Scholar
• 10 Ampel N M. Coccidioidomycosis in persons infected with HIV type 1.  Clin Infect Dis. 2005;  41 1174-1178
  CrossrefPubMedGoogle Scholar
• 11 Wright P W, Pappagiannis D, Wilson M et al.. Donor-related coccidioidomycosis in organ transplant recipients.  Clin Infect Dis. 2003;  37 1265-1269
  CrossrefPubMedGoogle Scholar
• 12 Blair J E, Smilack J D, Caples S M. Coccidioidomycosis in patients with hematologic malignancies.  Arch Intern Med. 2005;  165 113-117
  CrossrefPubMedGoogle Scholar
• 13 Crum N F, Lederman E R, Stafford C M et al.. Coccidioidomycosis: a descriptive survey of a reemerging disease: clinical characteristics and emerging controversies.  Medicine (Baltimore). 2004;  83 149-175
  CrossrefPubMedGoogle Scholar
• 14 Deresinski S C, Pappagianis D, Stevens D. Association of ABO blood group and outcome of coccidioidal infections.  Sabouraudia. 1979;  17 261-264
  PubMedGoogle Scholar
• 15 Rosenstein N E, Emery K W, Werner S B et al.. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern county, California, 1995-1996.  Clin Infect Dis. 2001;  32 708-714
  CrossrefPubMedGoogle Scholar
• 16 Johnson R H, Caldwell J W, Welch G, Einstein H E. The great coccidioidomycosis epidemic: clinical features. In: Proceedings of the 5th International Conference Stanford University August 24-27, 1994: 77-87
  Google Scholar
• 17 Bayer A S. Fungal pneumonias; pulmonary coccidioidal syndromes, I: Primary and progressive primary coccidioidal pneumonias-diagnostic therapeutic, and prognostic considerations.  Chest. 1981;  79 575-583
  CrossrefPubMedGoogle Scholar
• 18 Lonky S A, Catanzaro A, Moser K M, Einstein H. Acute coccidioidal pleural effusion.  Am Rev Respir Dis. 1976;  114 681-688
  PubMedGoogle Scholar
• 19 Bayer A S. Fungal pneumonias: pulmonary coccidioidal syndromes, II: Miliary, nodular, and cavitary pulmonary coccidioidomycosis; chemotherapeutic and surgical considerations.  Chest. 1981;  79 686-691
  CrossrefPubMedGoogle Scholar
• 20 Anstead G M, Graybill J R. Coccidioidomycosis.  Infect Dis Clin North Am. 2006;  20 621-643
  CrossrefPubMedGoogle Scholar
• 21 Galgiani J N. Coccidioidomycosis.  West J Med. 1993;  159 153-171
  PubMedGoogle Scholar
• 22 Winn R E, Johnson R, Galgiani J N, Butler C, Pluss J. Cavitary coccidioidomycosis with fungus ball formation: diagnosis by fiberoptic bronchoscopy with coexistence of hyphae and spherules.  Chest. 1994;  105 412-416
  CrossrefPubMedGoogle Scholar
• 23 Galgiani J N, Ampel N M, Blair J E et al.. Coccidioidomycosis.  Clin Infect Dis. 2005;  41 1217-1223
  CrossrefPubMedGoogle Scholar
• 24 Arsura E L, Kilgore W B. Miliary coccidioidomycosis in the immunocompetent.  Chest. 2000;  117 404-409
  CrossrefPubMedGoogle Scholar
• 25 Spinello I M, Johnson R H. A 19-year-old pregnant woman with a skin lesion and respiratory failure.  Chest. 2006;  130 611-615
  CrossrefPubMedGoogle Scholar
• 26 Shibli M, Ghassibi J, Hajal R, O'Sullivan M. Adjunctive corticosteroids therapy in acute respiratory syndrome owing to disseminated coccidioidomycosis.  Crit Care Med. 2002;  30 1896-1898
  CrossrefPubMedGoogle Scholar
• 27 Sajit S, Spinello I M, Munoz A, Johnson R H. Respiratory failure in pulmonary coccidioidomycosis: is there a role for steroids?. Proceedings of the 48th annual coccidioidomycosis study group meeting April 3, 2004 Rosarito, Mexico;
  Google Scholar
• 28 Bozzette S A, Sattler F R, Chiu J et al.. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.  N Engl J Med. 1990;  323 1451-1457
  CrossrefPubMedGoogle Scholar
• 29 Rempe S, Sachdev M S, Bhakta R, Pineda-Roman M, Vaz A, Carlson R W. Coccidioides immitis fungemia: clinical features and survival in 33 adult patients.  Heart Lung. 2007;  36 64-71
  CrossrefPubMedGoogle Scholar
• 30 Ahmed A J, Kruse J A, Haupt M T, Chandrasekar P H, Carlson R W. Hemodynamic responses to gram-positive versus gram-negative sepsis in critically ill patients with and without circulatory shock.  Crit Care Med. 1991;  19 1520-1525
  PubMedGoogle Scholar
• 31 Blair J E, Logan J L. Coccidioidomycosis in solid organ transplantation.  Clin Infect Dis. 2001;  33 1536-1544
  CrossrefPubMedGoogle Scholar
• 32 Blair J E. Coccidioidal pneumonia, arthritis, and soft tissue infection after kidney transplantation.  Transpl Infect Dis. 2004;  6 74-76
  CrossrefPubMedGoogle Scholar
• 33 Logan J L, Blair J E, Galgiani J N. Coccidioidomycosis complicating solid organ transplantation.  Semin Respir Infect. 2001;  16 251-256
  CrossrefPubMedGoogle Scholar
• 34 Tripathy U, Yung G L, Kriett J M et al.. Donor transfer of pulmonary coccidioidomycosis in lung transplantation.  Ann Thorac Surg. 2002;  73 306-308
  CrossrefPubMedGoogle Scholar
• 35 Blair J E, Douglas D D, Mulligan D C. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area.  Transpl Infect Dis. 2003;  5 3-8
  CrossrefPubMedGoogle Scholar
• 36 Miller M B, Hendren R, Gilligan P H. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs.  J Clin Microbiol. 2004;  42 2347-2349
  CrossrefPubMedGoogle Scholar
• 37 Hall K A, Sethi G K, Rosado L J et al.. Coccidioidomycosis and heart transplantation.  J Heart Lung Transplant. 1993;  12 525-526
  PubMedGoogle Scholar
• 38 Pappagianis D. Epidemiology of coccidioidomycosis. In: Stevens D Coccidioidomycosis. New York; Plenum 1980: 63-85
  Google Scholar
• 39 Crum N F, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature.  Am J Med. 2006;  119 993.e11-17
  PubMedGoogle Scholar
• 40 Ostrosky-Zeichner L, Marr K A, Rex J H et al.. Amphotericin B: time for a new “gold standard”.  Clin Infect Dis. 2003;  37 415-425
  CrossrefPubMedGoogle Scholar
• 41 Deresinski S C. Coccidioidomycosis: efficacy of new agents and future prospects.  Curr Opin Infect Dis. 2001;  14 693-696
  PubMedGoogle Scholar
• 42 Hostetler J S, Heykants J, Clemons K V et al.. Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations.  Antimicrob Agents Chemother. 1993;  37 2224-2227
  PubMedGoogle Scholar
• 43 McCarthy K L, Playford G, Looke D FM, Whitby M. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.  Clin Infect Dis. 2007;  44 e55-e56
  CrossrefPubMedGoogle Scholar
• 44 Walsh T J, Finberg R W, Arndt C et al.. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia.  N Engl J Med. 1999;  340 764-771
  CrossrefPubMedGoogle Scholar
• 45 Graybill J R, Stevens D A, Galgiani J N, Dismukes W E, Cloud G A. Itraconazole treatment of coccidioidomycosis. NIAID Mycoses Study Group.  Am J Med. 1990;  89 282-290
  CrossrefPubMedGoogle Scholar
• 46 Galgiani J N, Stevens D A, Graybill J R, Dismukes W E, Cloud G A. Ketoconazole therapy of progressive coccidioidomycosis: comparison of 400 and 800 mg doses and observations at higher doses.  Am J Med. 1988;  84 603-610
  CrossrefPubMedGoogle Scholar
• 47 Catanzaro A, Galgiani J N, Levine B E et al.. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis.  Am J Med. 1995;  98 249-256
  CrossrefPubMedGoogle Scholar

Irene M SpinelloM.D. 

Critical Care and Pulmonary Services, Kern Medical Center

1830 Flower St., Bakersfield, CA 93305

Email: spinelloi@kernmedctr.com